8-K - IGC Pharma, Inc. | StockGist

Current Report Details

Event Type

Material Agreement

Exhibits Only

Disclosure

Mandatory

Variant

8-K

Items Reported

1.01

Entry into a Material Definitive Agreement. On January 5, 2026, IGC Pharma, Inc. (“IGC” or the “Company”) entered into a Subscription Agreement (the “2025 Subsc

Material Agreement

$234.0K

Source Document

9.01

Financial Statements and Exhibits. (d) Exhibits Exhibit No. Description 5.1 Opinion of Olshan Frome Wolosky LLP. 10.1 Subscription Agreement, among the Company

Exhibits Only

Exhibits (3)

10.1

EXHIBIT 10.1

5.1

EXHIBIT 5.1

8-K

FORM 8-K